ResMed shares have been caught up in the recent market volatility. Has this created a buying window for ResMed shares?

ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Shares of ResMed Inc. RMD advanced 5.82% to $216.44 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to 5,456.90 and ...

Shares of ResMed Inc. RMD slipped 3.97% to $204.54 Tuesday, on what proved to be an all-around poor trading session for the ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.  | ...

Let's see what the broker is saying about these healthcare stocks. The post Trump 2.0: Macquarie's take on the winners and ...

SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.

FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosisSAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...

Which is the better option for ASX investors, Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) or ResMed Inc. (ASX: RMD) ...

In a welcome move, ResMed saw its Relative Strength Rating rise from 65 to 78 on Tuesday. Please watch the video at Investors ...

StockNews.com downgraded shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other equities research ...

Leading health technology, Resmed, has announced its home sleep apnea test, NightOwl, is now available across the United ...